Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.

International journal of medical informatics - 1 Nov 2020

Araya Alejandro, Zeng Jia, Johnson Amber, Shufean Md Abu, Rodon Jordi, Meric-Bernstam Funda, Bernstam Elmer V

Abstract excerpt

PURPOSE: Genomic analysis of individual patients is now affordable, and therapies targeting specific molecular aberrations are being tested in clinical trials. Genomically-informed therapy is relevant to many clinical domains, but is particularly applicable to cancer treatment. However, even specialized clinicians need help to interpret genomic data, to navigate the complicated space of clinical trials, and to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to Medical Oncology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 32889387
DOI: 10.1016/j.ijmedinf.2020.104261
PMCID: PMC9131704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.PMID 32889387Read ↗

Clinical Use of Precision Oncology Decision SupportSemantic proximity Read ↗

Precision Oncology Decision Support: Current Approaches and Strategies for the Future.Semantic proximity Read ↗

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemSemantic proximity Read ↗

Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).Semantic proximity Read ↗

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.Semantic proximity Read ↗

Precision Oncology: Who, How, What, When, and When Not?Semantic proximity Read ↗

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologySemantic proximity Read ↗

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.Semantic proximity Read ↗

Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven OncologySemantic proximity Read ↗

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University ExperienceSemantic proximity Read ↗

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options: the PRECODE study protocolSemantic proximity Read ↗

A decision support framework for genomically informed investigational cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.